Justin Byers, founder and CEO of Axio BioPharma argues pharma’s real bottleneck isn’t science. It’s broken data flow between labs and manufacturers.
Author: Gilang Kharisma
Source: Tech in Asia


Justin Byers, founder and CEO of Axio BioPharma argues pharma’s real bottleneck isn’t science. It’s broken data flow between labs and manufacturers.
Author: Gilang Kharisma
Source: Tech in Asia
